Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs.
Valeria Sanabria GuillenYvonne ZieglerChirag GopinathSandeep KumarParama DeyBlake N PlotnerNadia Z DawsonSung Hoon KimJohn A KatzenellenbogenBenita S KatzenellenbogenPublished in: Breast cancer research and treatment (2023)
The findings suggest that the combination of FOXM1 inhibitors with several other drugs might enable dose reduction in both agents and provide enhanced efficacy in treatment of breast cancer.